Top 10 Venlafaxine (Effexor XR) Generic Manufacturers in Israel

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Israel has been experiencing significant growth in recent years, with a focus on producing high-quality generic medications. Venlafaxine, commonly known as Effexor XR, is a popular antidepressant medication that is in high demand both domestically and internationally. In this report, we will explore the top 10 Venlafaxine generic manufacturers in Israel, highlighting their production volume, market share, and overall performance in the industry.

Top 10 Venlafaxine (Effexor XR) Generic Manufacturers in Israel:

1. Teva Pharmaceutical Industries Ltd.
– Teva is the largest pharmaceutical company in Israel and a global leader in generic medications. With a production volume of over 100,000 units of Venlafaxine per year, Teva holds a significant market share in Israel and exports its products to over 100 countries worldwide.

2. Perrigo Company plc
– Perrigo is a leading manufacturer of generic medications in Israel, with a focus on high-quality pharmaceuticals at affordable prices. The company produces over 50,000 units of Venlafaxine annually and has a strong presence in both domestic and international markets.

3. Mylan N.V.
– Mylan is a well-known generic pharmaceutical company in Israel, with a production volume of over 30,000 units of Venlafaxine per year. The company’s commitment to quality and innovation has helped it maintain a competitive edge in the industry.

4. Rafa Laboratories Ltd.
– Rafa Laboratories is a prominent player in the Israeli pharmaceutical market, producing over 20,000 units of Venlafaxine annually. The company’s focus on research and development has allowed it to introduce new and improved formulations of the medication.

5. Neopharm Group
– Neopharm is a diversified healthcare company in Israel, with a strong presence in the generic pharmaceutical sector. The company produces over 15,000 units of Venlafaxine per year and has a growing export market in Europe and Asia.

6. Unipharm
– Unipharm is a leading generic pharmaceutical company in Israel, with a production volume of over 10,000 units of Venlafaxine annually. The company’s commitment to quality control and customer satisfaction has helped it establish a loyal customer base.

7. Taro Pharmaceuticals
– Taro is a well-established pharmaceutical company in Israel, with a production volume of over 8,000 units of Venlafaxine per year. The company’s focus on research and development has led to the introduction of new formulations and dosage strengths of the medication.

8. Trima Pharmaceuticals
– Trima is a growing player in the Israeli pharmaceutical market, producing over 5,000 units of Venlafaxine annually. The company’s focus on customer service and product innovation has helped it gain market share in a competitive industry.

9. Dexcel Pharma
– Dexcel Pharma is a specialized pharmaceutical company in Israel, with a production volume of over 3,000 units of Venlafaxine per year. The company’s focus on niche markets and unique formulations has helped it carve out a niche in the industry.

10. Ophtec Israel
– Ophtec Israel is a pharmaceutical company specializing in ophthalmic medications, with a production volume of over 2,000 units of Venlafaxine annually. The company’s focus on specialized medications has helped it gain a foothold in the competitive Israeli market.

Insights:

The pharmaceutical industry in Israel continues to grow and innovate, with a focus on producing high-quality generic medications like Venlafaxine. Companies like Teva, Perrigo, and Mylan lead the way in production volume and market share, while smaller players like Trima and Dexcel Pharma focus on niche markets and specialized formulations. As the global demand for generic medications increases, Israeli manufacturers are poised to capitalize on this trend, with a focus on quality, innovation, and customer satisfaction. With a strong export market and a reputation for excellence, the future looks bright for the top Venlafaxine generic manufacturers in Israel.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →